カテゴリ： QYResearch, 世界, 医療/バイオ

腎臓がん診断の世界市場2023年：免疫組織化学検査、血算検査、尿検査、血液生化学検査

■ 英語タイトル：Global Kidney Cancer Diagnosis Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8024）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8024
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：88
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[腎臓がん診断の世界市場2023年：免疫組織化学検査、血算検査、尿検査、血液生化学検査]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は腎臓がん診断のグローバル市場について調査・分析し、世界の腎臓がん診断市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（免疫組織化学検査、血算検査、尿検査、血液生化学検査）、用途別セグメント分析（病院、手術センター）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Myriad Genetics Inc.、NeoGenomics Laboratories、Thermo Fisher Scientific Inc.、Sysmex Corporation、Rosetta Genomics、Illumina Inc.、Abbott Laboratories、Roche Holding AGなどが含まれています。腎臓がん診断のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、腎臓がん診断市場規模を算出する際に考慮しました。

・腎臓がん診断市場の概要
- 製品の定義
- 腎臓がん診断の種類別セグメント
- 世界の腎臓がん診断市場規模：タイプ別分析（免疫組織化学検査、血算検査、尿検査、血液生化学検査）
- 腎臓がん診断の用途別セグメント
- 世界の腎臓がん診断市場規模：用途別分析（病院、手術センター）
- 世界の腎臓がん診断市場規模予測（2018年-2029年）
- 腎臓がん診断の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 腎臓がん診断市場の競争状況およびトレンド

・腎臓がん診断の地域別市場規模
- 北米の腎臓がん診断市場規模（2018年-2029年）
- 米国の腎臓がん診断市場規模（2018年-2029年）
- ヨーロッパの腎臓がん診断市場規模（2018年-2029年）
- アジア太平洋の腎臓がん診断市場規模（2018年-2029年）
- 中国の腎臓がん診断市場規模（2018年-2029年）
- 日本の腎臓がん診断市場規模（2018年-2029年）
- 韓国の腎臓がん診断市場規模（2018年-2029年）
- インドの腎臓がん診断市場規模（2018年-2029年）
- オーストラリアの腎臓がん診断市場規模（2018年-2029年）
- 中南米の腎臓がん診断市場規模（2018年-2029年）
- 中東・アフリカの腎臓がん診断市場規模（2018年-2029年）

・種類別セグメント：免疫組織化学検査、血算検査、尿検査、血液生化学検査
- 世界の腎臓がん診断のタイプ別販売量（2018年-2023年）
- 世界の腎臓がん診断のタイプ別売上（2018年-2023年）
- 世界の腎臓がん診断のタイプ別価格

・用途別セグメント：病院、手術センター
- 世界の腎臓がん診断の用途別販売量（2018年-2023年）
- 世界の腎臓がん診断の用途別売上（2018年-2023年）
- 世界の腎臓がん診断の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Myriad Genetics Inc.、NeoGenomics Laboratories、Thermo Fisher Scientific Inc.、Sysmex Corporation、Rosetta Genomics、Illumina Inc.、Abbott Laboratories、Roche Holding AG

・産業チェーンと販売チャネルの分析
- 腎臓がん診断産業チェーン分析
- 腎臓がん診断の主要原材料
- 腎臓がん診断の販売チャネル
- 腎臓がん診断のディストリビューター
- 腎臓がん診断の主要顧客

・腎臓がん診断市場ダイナミクス
- 腎臓がん診断の業界動向
- 腎臓がん診断市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Kidney Cancer Diagnosis market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Kidney Cancer Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Kidney Cancer Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Kidney Cancer Diagnosis include Myriad Genetics Inc., NeoGenomics Laboratories, Thermo Fisher Scientific Inc., Sysmex Corporation, Rosetta Genomics, Illumina Inc., Abbott Laboratories and Roche Holding AG, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer Diagnosis.
The Kidney Cancer Diagnosis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Kidney Cancer Diagnosis market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kidney Cancer Diagnosis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Myriad Genetics Inc.
NeoGenomics Laboratories
Thermo Fisher Scientific Inc.
Sysmex Corporation
Rosetta Genomics
Illumina Inc.
Abbott Laboratories
Roche Holding AG
Segment by Type
Immunohistochemical Test
Complete Blood Count Test
Urine Test
Blood Chemistry Test
Segment by Application
Hospital
Surgery Center
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Kidney Cancer Diagnosis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Kidney Cancer Diagnosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Kidney Cancer Diagnosis Market Overview
1.1 Product Overview and Scope of Kidney Cancer Diagnosis
1.2 Kidney Cancer Diagnosis Segment by Type
1.2.1 Global Kidney Cancer Diagnosis Market Value Comparison by Type (2023-2029)
1.2.2 Immunohistochemical Test
1.2.3 Complete Blood Count Test
1.2.4 Urine Test
1.2.5 Blood Chemistry Test
1.3 Kidney Cancer Diagnosis Segment by Application
1.3.1 Global Kidney Cancer Diagnosis Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Surgery Center
1.4 Global Kidney Cancer Diagnosis Market Size Estimates and Forecasts
1.4.1 Global Kidney Cancer Diagnosis Revenue 2018-2029
1.4.2 Global Kidney Cancer Diagnosis Sales 2018-2029
1.4.3 Global Kidney Cancer Diagnosis Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Kidney Cancer Diagnosis Market Competition by Manufacturers
2.1 Global Kidney Cancer Diagnosis Sales Market Share by Manufacturers (2018-2023)
2.2 Global Kidney Cancer Diagnosis Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Kidney Cancer Diagnosis Average Price by Manufacturers (2018-2023)
2.4 Global Kidney Cancer Diagnosis Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Kidney Cancer Diagnosis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Kidney Cancer Diagnosis, Product Type & Application
2.7 Kidney Cancer Diagnosis Market Competitive Situation and Trends
2.7.1 Kidney Cancer Diagnosis Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Kidney Cancer Diagnosis Players Market Share by Revenue
2.7.3 Global Kidney Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Kidney Cancer Diagnosis Retrospective Market Scenario by Region
3.1 Global Kidney Cancer Diagnosis Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Kidney Cancer Diagnosis Global Kidney Cancer Diagnosis Sales by Region: 2018-2029
3.2.1 Global Kidney Cancer Diagnosis Sales by Region: 2018-2023
3.2.2 Global Kidney Cancer Diagnosis Sales by Region: 2024-2029
3.3 Global Kidney Cancer Diagnosis Global Kidney Cancer Diagnosis Revenue by Region: 2018-2029
3.3.1 Global Kidney Cancer Diagnosis Revenue by Region: 2018-2023
3.3.2 Global Kidney Cancer Diagnosis Revenue by Region: 2024-2029
3.4 North America Kidney Cancer Diagnosis Market Facts & Figures by Country
3.4.1 North America Kidney Cancer Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Kidney Cancer Diagnosis Sales by Country (2018-2029)
3.4.3 North America Kidney Cancer Diagnosis Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Kidney Cancer Diagnosis Market Facts & Figures by Country
3.5.1 Europe Kidney Cancer Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Kidney Cancer Diagnosis Sales by Country (2018-2029)
3.5.3 Europe Kidney Cancer Diagnosis Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Kidney Cancer Diagnosis Market Facts & Figures by Country
3.6.1 Asia Pacific Kidney Cancer Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Kidney Cancer Diagnosis Sales by Country (2018-2029)
3.6.3 Asia Pacific Kidney Cancer Diagnosis Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Kidney Cancer Diagnosis Market Facts & Figures by Country
3.7.1 Latin America Kidney Cancer Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Kidney Cancer Diagnosis Sales by Country (2018-2029)
3.7.3 Latin America Kidney Cancer Diagnosis Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Kidney Cancer Diagnosis Market Facts & Figures by Country
3.8.1 Middle East and Africa Kidney Cancer Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Kidney Cancer Diagnosis Sales by Country (2018-2029)
3.8.3 Middle East and Africa Kidney Cancer Diagnosis Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Kidney Cancer Diagnosis Sales by Type (2018-2029)
4.1.1 Global Kidney Cancer Diagnosis Sales by Type (2018-2023)
4.1.2 Global Kidney Cancer Diagnosis Sales by Type (2024-2029)
4.1.3 Global Kidney Cancer Diagnosis Sales Market Share by Type (2018-2029)
4.2 Global Kidney Cancer Diagnosis Revenue by Type (2018-2029)
4.2.1 Global Kidney Cancer Diagnosis Revenue by Type (2018-2023)
4.2.2 Global Kidney Cancer Diagnosis Revenue by Type (2024-2029)
4.2.3 Global Kidney Cancer Diagnosis Revenue Market Share by Type (2018-2029)
4.3 Global Kidney Cancer Diagnosis Price by Type (2018-2029)
5 Segment by Application
5.1 Global Kidney Cancer Diagnosis Sales by Application (2018-2029)
5.1.1 Global Kidney Cancer Diagnosis Sales by Application (2018-2023)
5.1.2 Global Kidney Cancer Diagnosis Sales by Application (2024-2029)
5.1.3 Global Kidney Cancer Diagnosis Sales Market Share by Application (2018-2029)
5.2 Global Kidney Cancer Diagnosis Revenue by Application (2018-2029)
5.2.1 Global Kidney Cancer Diagnosis Revenue by Application (2018-2023)
5.2.2 Global Kidney Cancer Diagnosis Revenue by Application (2024-2029)
5.2.3 Global Kidney Cancer Diagnosis Revenue Market Share by Application (2018-2029)
5.3 Global Kidney Cancer Diagnosis Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Myriad Genetics Inc.
6.1.1 Myriad Genetics Inc. Corporation Information
6.1.2 Myriad Genetics Inc. Description and Business Overview
6.1.3 Myriad Genetics Inc. Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Myriad Genetics Inc. Kidney Cancer Diagnosis Product Portfolio
6.1.5 Myriad Genetics Inc. Recent Developments/Updates
6.2 NeoGenomics Laboratories
6.2.1 NeoGenomics Laboratories Corporation Information
6.2.2 NeoGenomics Laboratories Description and Business Overview
6.2.3 NeoGenomics Laboratories Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.2.4 NeoGenomics Laboratories Kidney Cancer Diagnosis Product Portfolio
6.2.5 NeoGenomics Laboratories Recent Developments/Updates
6.3 Thermo Fisher Scientific Inc.
6.3.1 Thermo Fisher Scientific Inc. Corporation Information
6.3.2 Thermo Fisher Scientific Inc. Description and Business Overview
6.3.3 Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Product Portfolio
6.3.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
6.4 Sysmex Corporation
6.4.1 Sysmex Corporation Corporation Information
6.4.2 Sysmex Corporation Description and Business Overview
6.4.3 Sysmex Corporation Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sysmex Corporation Kidney Cancer Diagnosis Product Portfolio
6.4.5 Sysmex Corporation Recent Developments/Updates
6.5 Rosetta Genomics
6.5.1 Rosetta Genomics Corporation Information
6.5.2 Rosetta Genomics Description and Business Overview
6.5.3 Rosetta Genomics Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Rosetta Genomics Kidney Cancer Diagnosis Product Portfolio
6.5.5 Rosetta Genomics Recent Developments/Updates
6.6 Illumina Inc.
6.6.1 Illumina Inc. Corporation Information
6.6.2 Illumina Inc. Description and Business Overview
6.6.3 Illumina Inc. Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Illumina Inc. Kidney Cancer Diagnosis Product Portfolio
6.6.5 Illumina Inc. Recent Developments/Updates
6.7 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbott Laboratories Kidney Cancer Diagnosis Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 Roche Holding AG
6.8.1 Roche Holding AG Corporation Information
6.8.2 Roche Holding AG Description and Business Overview
6.8.3 Roche Holding AG Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Roche Holding AG Kidney Cancer Diagnosis Product Portfolio
6.8.5 Roche Holding AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Kidney Cancer Diagnosis Industry Chain Analysis
7.2 Kidney Cancer Diagnosis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Kidney Cancer Diagnosis Production Mode & Process
7.4 Kidney Cancer Diagnosis Sales and Marketing
7.4.1 Kidney Cancer Diagnosis Sales Channels
7.4.2 Kidney Cancer Diagnosis Distributors
7.5 Kidney Cancer Diagnosis Customers
8 Kidney Cancer Diagnosis Market Dynamics
8.1 Kidney Cancer Diagnosis Industry Trends
8.2 Kidney Cancer Diagnosis Market Drivers
8.3 Kidney Cancer Diagnosis Market Challenges
8.4 Kidney Cancer Diagnosis Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Kidney Cancer Diagnosis Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Kidney Cancer Diagnosis Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Kidney Cancer Diagnosis Market Competitive Situation by Manufacturers in 2022
Table 4. Global Kidney Cancer Diagnosis Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Kidney Cancer Diagnosis Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Kidney Cancer Diagnosis Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Kidney Cancer Diagnosis Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Kidney Cancer Diagnosis Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Kidney Cancer Diagnosis, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Kidney Cancer Diagnosis, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Kidney Cancer Diagnosis, Product Type & Application
Table 12. Global Key Manufacturers of Kidney Cancer Diagnosis, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Kidney Cancer Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Diagnosis as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Kidney Cancer Diagnosis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Kidney Cancer Diagnosis Sales by Region (2018-2023) & (K Units)
Table 18. Global Kidney Cancer Diagnosis Sales Market Share by Region (2018-2023)
Table 19. Global Kidney Cancer Diagnosis Sales by Region (2024-2029) & (K Units)
Table 20. Global Kidney Cancer Diagnosis Sales Market Share by Region (2024-2029)
Table 21. Global Kidney Cancer Diagnosis Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Kidney Cancer Diagnosis Revenue Market Share by Region (2018-2023)
Table 23. Global Kidney Cancer Diagnosis Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Kidney Cancer Diagnosis Revenue Market Share by Region (2024-2029)
Table 25. North America Kidney Cancer Diagnosis Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Kidney Cancer Diagnosis Sales by Country (2018-2023) & (K Units)
Table 27. North America Kidney Cancer Diagnosis Sales by Country (2024-2029) & (K Units)
Table 28. North America Kidney Cancer Diagnosis Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Kidney Cancer Diagnosis Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Kidney Cancer Diagnosis Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Kidney Cancer Diagnosis Sales by Country (2018-2023) & (K Units)
Table 32. Europe Kidney Cancer Diagnosis Sales by Country (2024-2029) & (K Units)
Table 33. Europe Kidney Cancer Diagnosis Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Kidney Cancer Diagnosis Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Kidney Cancer Diagnosis Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Kidney Cancer Diagnosis Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Kidney Cancer Diagnosis Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Kidney Cancer Diagnosis Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Kidney Cancer Diagnosis Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Kidney Cancer Diagnosis Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Kidney Cancer Diagnosis Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Kidney Cancer Diagnosis Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Kidney Cancer Diagnosis Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Kidney Cancer Diagnosis Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Kidney Cancer Diagnosis Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Kidney Cancer Diagnosis Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Kidney Cancer Diagnosis Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Kidney Cancer Diagnosis Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Kidney Cancer Diagnosis Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Kidney Cancer Diagnosis Sales (K Units) by Type (2018-2023)
Table 51. Global Kidney Cancer Diagnosis Sales (K Units) by Type (2024-2029)
Table 52. Global Kidney Cancer Diagnosis Sales Market Share by Type (2018-2023)
Table 53. Global Kidney Cancer Diagnosis Sales Market Share by Type (2024-2029)
Table 54. Global Kidney Cancer Diagnosis Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Kidney Cancer Diagnosis Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Kidney Cancer Diagnosis Revenue Market Share by Type (2018-2023)
Table 57. Global Kidney Cancer Diagnosis Revenue Market Share by Type (2024-2029)
Table 58. Global Kidney Cancer Diagnosis Price (US$/Unit) by Type (2018-2023)
Table 59. Global Kidney Cancer Diagnosis Price (US$/Unit) by Type (2024-2029)
Table 60. Global Kidney Cancer Diagnosis Sales (K Units) by Application (2018-2023)
Table 61. Global Kidney Cancer Diagnosis Sales (K Units) by Application (2024-2029)
Table 62. Global Kidney Cancer Diagnosis Sales Market Share by Application (2018-2023)
Table 63. Global Kidney Cancer Diagnosis Sales Market Share by Application (2024-2029)
Table 64. Global Kidney Cancer Diagnosis Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Kidney Cancer Diagnosis Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Kidney Cancer Diagnosis Revenue Market Share by Application (2018-2023)
Table 67. Global Kidney Cancer Diagnosis Revenue Market Share by Application (2024-2029)
Table 68. Global Kidney Cancer Diagnosis Price (US$/Unit) by Application (2018-2023)
Table 69. Global Kidney Cancer Diagnosis Price (US$/Unit) by Application (2024-2029)
Table 70. Myriad Genetics Inc. Corporation Information
Table 71. Myriad Genetics Inc. Description and Business Overview
Table 72. Myriad Genetics Inc. Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Myriad Genetics Inc. Kidney Cancer Diagnosis Product
Table 74. Myriad Genetics Inc. Recent Developments/Updates
Table 75. NeoGenomics Laboratories Corporation Information
Table 76. NeoGenomics Laboratories Description and Business Overview
Table 77. NeoGenomics Laboratories Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. NeoGenomics Laboratories Kidney Cancer Diagnosis Product
Table 79. NeoGenomics Laboratories Recent Developments/Updates
Table 80. Thermo Fisher Scientific Inc. Corporation Information
Table 81. Thermo Fisher Scientific Inc. Description and Business Overview
Table 82. Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Product
Table 84. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 85. Sysmex Corporation Corporation Information
Table 86. Sysmex Corporation Description and Business Overview
Table 87. Sysmex Corporation Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Sysmex Corporation Kidney Cancer Diagnosis Product
Table 89. Sysmex Corporation Recent Developments/Updates
Table 90. Rosetta Genomics Corporation Information
Table 91. Rosetta Genomics Description and Business Overview
Table 92. Rosetta Genomics Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Rosetta Genomics Kidney Cancer Diagnosis Product
Table 94. Rosetta Genomics Recent Developments/Updates
Table 95. Illumina Inc. Corporation Information
Table 96. Illumina Inc. Description and Business Overview
Table 97. Illumina Inc. Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Illumina Inc. Kidney Cancer Diagnosis Product
Table 99. Illumina Inc. Recent Developments/Updates
Table 100. Abbott Laboratories Corporation Information
Table 101. Abbott Laboratories Description and Business Overview
Table 102. Abbott Laboratories Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Abbott Laboratories Kidney Cancer Diagnosis Product
Table 104. Abbott Laboratories Recent Developments/Updates
Table 105. Roche Holding AG Corporation Information
Table 106. Roche Holding AG Description and Business Overview
Table 107. Roche Holding AG Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Roche Holding AG Kidney Cancer Diagnosis Product
Table 109. Roche Holding AG Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Kidney Cancer Diagnosis Distributors List
Table 113. Kidney Cancer Diagnosis Customers List
Table 114. Kidney Cancer Diagnosis Market Trends
Table 115. Kidney Cancer Diagnosis Market Drivers
Table 116. Kidney Cancer Diagnosis Market Challenges
Table 117. Kidney Cancer Diagnosis Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Kidney Cancer Diagnosis
Figure 2. Global Kidney Cancer Diagnosis Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Kidney Cancer Diagnosis Market Share by Type in 2022 & 2029
Figure 4. Immunohistochemical Test Product Picture
Figure 5. Complete Blood Count Test Product Picture
Figure 6. Urine Test Product Picture
Figure 7. Blood Chemistry Test Product Picture
Figure 8. Global Kidney Cancer Diagnosis Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Kidney Cancer Diagnosis Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Surgery Center
Figure 12. Global Kidney Cancer Diagnosis Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Kidney Cancer Diagnosis Market Size (2018-2029) & (US$ Million)
Figure 14. Global Kidney Cancer Diagnosis Sales (2018-2029) & (K Units)
Figure 15. Global Kidney Cancer Diagnosis Average Price (US$/Unit) & (2018-2029)
Figure 16. Kidney Cancer Diagnosis Report Years Considered
Figure 17. Kidney Cancer Diagnosis Sales Share by Manufacturers in 2022
Figure 18. Global Kidney Cancer Diagnosis Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Kidney Cancer Diagnosis Players: Market Share by Revenue in 2022
Figure 20. Kidney Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Kidney Cancer Diagnosis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Kidney Cancer Diagnosis Sales Market Share by Country (2018-2029)
Figure 23. North America Kidney Cancer Diagnosis Revenue Market Share by Country (2018-2029)
Figure 24. United States Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Kidney Cancer Diagnosis Sales Market Share by Country (2018-2029)
Figure 27. Europe Kidney Cancer Diagnosis Revenue Market Share by Country (2018-2029)
Figure 28. Germany Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Kidney Cancer Diagnosis Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Kidney Cancer Diagnosis Revenue Market Share by Region (2018-2029)
Figure 35. China Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Kidney Cancer Diagnosis Sales Market Share by Country (2018-2029)
Figure 45. Latin America Kidney Cancer Diagnosis Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Kidney Cancer Diagnosis Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Kidney Cancer Diagnosis Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Kidney Cancer Diagnosis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Kidney Cancer Diagnosis by Type (2018-2029)
Figure 55. Global Revenue Market Share of Kidney Cancer Diagnosis by Type (2018-2029)
Figure 56. Global Kidney Cancer Diagnosis Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Kidney Cancer Diagnosis by Application (2018-2029)
Figure 58. Global Revenue Market Share of Kidney Cancer Diagnosis by Application (2018-2029)
Figure 59. Global Kidney Cancer Diagnosis Price (US$/Unit) by Application (2018-2029)
Figure 60. Kidney Cancer Diagnosis Value Chain
Figure 61. Kidney Cancer Diagnosis Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 卵巣がん診断のグローバル市場（2023年-2030年）：画像診断、血液検査、生検、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8024 )"腎臓がん診断の世界市場2023年：免疫組織化学検査、血算検査、尿検査、血液生化学検査" (英文：Global Kidney Cancer Diagnosis Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。